Reports
-
Medicare Could Have Saved Up To $128 Million Over 5 Years if CMS Had Implemented Controls To Address Duplicate Payments for Services Provided to Individuals With Medicare and Veterans Health Administration Benefits
-
Toolkit: Analyzing Telehealth Claims to Assess Program Integrity Risks
-
Modification of Advisory Opinion 20-04
-
Medicare Advantage Compliance Audit of Specific Diagnosis Codes That HumanaChoice (Contract H6609) Submitted to CMS
-
Testimony of Christi A. Grimm
-
CMS Did Not Accurately Report on Care Compare One or More Deficiencies Related to Health, Fire Safety, and Emergency Preparedness for an Estimated Two-Thirds of Nursing Homes
-
Texas Could Not Support the Permissibility of the Funds Used as the State Share of the Medicaid Delivery System Reform Incentive Payment Program
-
Medicare Advantage Compliance Audit of Specific Diagnosis Codes That Cigna-HealthSpring Life & Health Insurance Company, Inc. (Contract H4513) Submitted to CMS
-
Advisory Opinion 23-03
-
Medicare Advantage Compliance Audit of Specific Diagnosis Codes That MCS Advantage, Inc. (Contract H5577) Submitted to CMS
-
Maryland Child Support Administration Generally Claimed Administrative Costs That Were Allowable and Allocable
-
Medicare Improperly Paid Physicians an Estimated $30 Million for Spinal Facet-Joint Interventions
-
The District of Columbia Has Taken Significant Steps To Ensure Accountability Over Amounts Managed Care Organizations Paid to Pharmacy Benefit Managers
-
Medicare Advantage Compliance Audit of Specific Diagnosis Codes That Geisinger Health Plan (Contract H3954) Submitted to CMS
-
Georgia Did Not Always Invoice Rebates to Manufacturers for Pharmacy and Physician-Administered Drugs
-
Some Skin Substitute Manufacturers Did Not Comply with New ASP Reporting Requirements
-
FY 2024 Congressional Budget Justification
-
Medicare Improperly Paid Physicians for Epidural Steroid Injection Sessions
-
Michigan MMIS and E&E Systems Security Controls Were Generally Effective, but Some Improvements Are Needed
-
Florida Did Not Invoice Manufacturers for Some Rebates for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations